01 1Alliance revenue - Lynparza
02 14Lynparza
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,776
2019 Revenue in Millions : 1,198
Growth (%) : 48
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,348
2020 Revenue in Millions : 1,776
Growth (%) : 32
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 725
2019 Revenue in Millions : 444
Growth (%) : 63
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 989
2020 Revenue in Millions : 725
Growth (%) : 36
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 2,638
2021 Revenue in Millions : 2,348
Growth (%) : 12